S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

NCT02177695 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

237

Enrollment

NETWORK

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: Gemcitabine
DRUG: Cisplatin
DRUG: Methotrexate
DRUG: Vinblastine
DRUG: Doxorubicin
DRUG: Filgrastim

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]